novemb
april
virolog
laboratori
univers
hospit
caen
franc
receiv
respiratori
sampl
nasal
aspir
swab
patient
year
age
specimen
test
influenza
viru
b
respiratori
syncyti
viru
rsv
parainfluenza
viru
adenoviru
direct
indirect
immunofluoresc
viru
isol
sampl
also
test
human
metapneumoviru
hmpv
rhinoviru
enteroviru
hcov
viru
isol
rtpcr
total
sampl
posit
virus
symptom
indic
viral
infect
judg
clinic
depart
therefor
sampl
test
bacteri
pathogen
posit
sampl
follow
respiratori
virus
detect
rsv
n
rhinoviru
n
influenza
viru
b
n
hmpv
n
n
detect
neg
sampl
per
month
test
sampl
repres
patient
year
age
patient
year
age
patient
year
age
patient
hospit
acut
respiratori
tract
ill
data
patient
record
infect
avail
examin
retrospect
specif
respiratori
symptom
patient
consent
sampl
test
respiratori
virus
includ
coronavirus
two
rtpcr
assay
use
detect
respiratori
sampl
rna
extract
use
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
accord
manufactur
instruct
first
rtpcr
assay
simpl
rtpcr
amplifi
fragment
nucleocapsid
n
gene
use
follow
primer
second
assay
multiplex
rtpcr
amplifi
fragment
n
gene
fragment
membran
gene
fragment
gene
use
previous
describ
primer
assay
onestep
rtpcr
kit
qiagen
undertaken
reaction
volum
contain
rna
extract
qiagen
onestep
rtpcr
buffer
mmoll
deoxynucleosid
triphosph
dntp
qiagen
onestep
rtpcr
enzym
mix
mmoll
primer
qiagen
onestep
rtpcr
kit
q
solut
rnasefre
water
reaction
carri
geneamp
pcr
system
thermal
cycler
appli
biosystem
foster
citi
ca
usa
initi
revers
transcript
step
min
follow
pcr
activ
min
cycl
amplif
min
final
extens
step
min
rtpcr
test
includ
water
control
treat
ident
viru
sampl
throughout
perform
usual
precaut
avoid
contamin
rtpcr
product
subject
electrophoresi
agaros
gel
stain
ethidium
bromid
visual
uv
light
compar
analyt
sensit
simpl
multiplex
rtpcr
assay
previous
studi
prototyp
strain
analyz
serial
dilut
posit
control
hcov
analyt
sensit
equival
detect
multiplex
assay
sensit
one
dilut
detect
less
sensit
one
dilut
detect
data
shown
crossreact
test
observ
coronavirus
sampl
posit
hcov
confirm
use
dna
enzym
immunoassay
genetik
deia
sorin
saluggia
itali
carri
recommend
manufactur
origin
probe
previous
describ
hcov
follow
probe
defin
n
gene
biotin
third
rtpcr
assay
carri
sampl
amplifi
fragment
spike
primer
posit
posit
assay
perform
essenti
describ
rtpcr
product
purifi
use
exosapit
usb
corpor
cleveland
oh
usa
sequenc
primer
use
ceq
dye
termin
cycl
sequenc
quick
start
kit
ceq
genet
analysi
system
beckman
coulter
fullerton
ca
usa
nucleotid
sequenc
partial
gene
genbank
access
no
compar
prototyp
sequenc
avail
genbank
nl
nucleotid
predict
amino
acid
sequenc
align
prepar
use
clustalx
version
phylogenet
tree
construct
use
outgroup
detect
sampl
evalu
novemb
april
twentytwo
sampl
posit
simpl
multiplex
rtpcr
figur
discord
result
found
remain
sampl
posit
simpl
rtpcr
posit
multiplex
rtpcr
discord
sampl
control
use
method
rna
extract
product
result
obtain
ident
specif
rtpcr
product
uv
confirm
hybrid
multiplex
rtpcr
identifi
sampl
sampl
sampl
obtain
patient
year
age
patient
year
age
patient
year
age
age
distribut
patient
infect
ident
age
distribut
sampl
posit
specimen
collect
throughout
studi
period
epidem
observ
tempor
distribut
infect
shown
figur
patient
includ
studi
respiratori
tract
ill
medic
report
patient
sampl
retrospect
examin
follow
symptom
note
fever
n
rhiniti
n
lower
respiratori
tract
ill
bronchiol
pneumonia
n
digest
problem
diarrhea
abdomin
pain
n
otiti
n
pharyng
n
conjunct
n
one
patient
sever
underli
diseas
congenit
immunodefici
upper
respiratori
tract
ill
fever
anoth
famili
histori
atop
allergi
pneumonia
diagnos
overal
one
third
patient
infect
sever
lower
respiratori
tract
infect
bronchiol
pneumonia
recov
complet
determin
isol
franc
contain
differ
genet
marker
sequenc
part
protein
gene
isol
molecular
analysi
phylogenet
analysi
show
isol
franc
diverg
group
contain
sequenc
differ
marker
one
isol
characterist
outlier
figur
phylogenet
analysi
predict
amino
acid
sequenc
also
show
isol
outlier
figur
howev
branch
tree
base
amino
acid
differ
care
taken
limit
inform
site
sequenc
number
virus
caus
respiratori
infect
mani
infect
attribut
known
pathogen
fact
may
detect
method
lack
sensit
respiratori
virus
systemat
test
pathogen
yet
identifi
novel
agent
hmpv
sarscov
identifi
recent
coronavirus
coronavirus
infect
mani
speci
mammal
bird
possess
largest
genom
rna
virus
kb
high
frequenc
recombin
addit
potenti
infect
speci
describ
bovin
coronaviru
suspect
caus
sar
outbreak
therefor
coronavirus
repres
potenti
major
infecti
agent
human
base
genotyp
serolog
characterist
coronavirus
divid
distinct
group
hcov
group
hcov
group
sarscov
definit
assign
group
howev
earli
splitoff
sarscov
group
lineag
suggest
recent
hcov
sarscov
thoroughli
studi
suggest
epidemiolog
survey
conduct
human
coronavirus
distribut
worldwid
circul
season
outbreak
studi
determin
whether
also
case
furthermor
look
symptom
infect
heterogen
viru
isol
circul
franc
studi
sampl
posit
result
suggest
frequent
caus
infect
particularli
young
children
avail
sampl
test
neg
respiratori
virus
includ
studi
consequ
could
identifi
coinfect
nevertheless
use
multiplex
rtpcr
simultan
detect
classic
human
coronavirus
detect
coinfect
hcov
sampl
addit
case
infect
patient
explain
fact
multiplex
rtpcr
perform
directli
respiratori
sampl
wherea
previou
routin
test
sampl
first
instil
cell
cultur
system
cell
line
rtpcr
perform
cell
cultur
supernat
detect
human
respiratori
coronavirus
requir
molecular
techniqu
difficulti
viru
cultur
lack
assay
detect
intracellular
antigen
other
serolog
assay
multiplex
rtpcr
therefor
use
tool
simultan
test
variou
hcov
clinic
sampl
studi
show
clinic
sensit
multiplex
rtpcr
equival
simpl
rtpcr
allow
clinic
studi
routin
test
detect
sampl
hcov
belong
antigen
group
percentag
amino
acid
sequenc
ident
n
protein
hcov
respect
crossprotect
immun
respons
could
explain
human
coronavirus
circul
time
detect
respiratori
specimen
februari
frequenc
result
correl
fact
human
coronavirus
circul
primarili
winter
howev
found
nasal
aspir
month
studi
clinic
symptom
associ
still
need
determin
patient
studi
symptom
includ
respiratori
symptom
also
lower
respiratori
tract
diseas
bronchiol
bronchiti
pneumonia
human
coronavirus
except
sarscov
gener
caus
diseas
much
like
common
cold
also
associ
sever
lower
respiratori
tract
condit
especi
frail
patient
whether
also
respons
coldlik
ill
healthi
adult
describ
hcov
must
determin
said
recent
describ
coronaviru
viru
identifi
patient
chronic
obstruct
airway
diseas
hospit
pneumonia
digest
problem
note
approxim
one
third
patient
clear
evid
exist
human
coronavirus
except
sarscov
caus
enter
ill
previou
studi
suggest
virus
may
involv
enter
diseas
studi
must
conduct
detect
coronavirus
stool
sampl
clarifi
origin
digest
symptom
protein
coronavirus
major
determin
cell
tropism
pathogen
major
induc
neutral
antibodi
furthermor
heterogen
gene
observ
differ
strain
amplifi
part
gene
studi
variabl
isol
phylogenet
analysi
show
sever
differ
isol
cocircul
franc
similar
situat
netherland
australia
canada
belgium
conclus
found
patient
upper
lower
respiratori
tract
ill
particularli
hospit
children
observ
first
infect
franc
sever
isol
found
circul
countri
sensit
multiplex
rtpcr
hcov
develop
use
tool
facilit
routin
detect
pathogen
project
support
european
commiss
episar
contract
programm
de
recherch
en
francochinoi
du
sra
de
au
